The Cochlear™ Nucleus® implant system features a range of options we designed to meet your individual hearing needs and to provide you with high-quality hearing performance.
There are two main components of the Cochlear™ Nucleus® system: an internal implant and an external sound processor.
While hearing health professionals will help match suitable implants for hearing needs, there are a variety of sound processors to suit your lifestyle and hearing preferences.
Explore your options and learn more about the convenience of Cochlear’s exclusive wireless technology.
With the most reliable implants in the industry,1-3 your hearing is in good hands.
Nucleus® sound processors
Benefit from technology that can help you hear your best, connect to the people you love and experience a world of possibilities.
Our Cochlear implants support a lifetime of hearing. Engineered with precision, they provide a natural fit and preserve the long-term health of the cochlea.
Smart Bimodal hearing
Hear your best with both ears. Discover Smart Bimodal hearing from Cochlear and ReSound.
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
Cochlear Limited. D193280. Cochlear Nucleus Reliability Report Volume 20 December 2021. 2022, March.
Cochlear Implant Reliability | MED-EL [Internet]. Medel.com. 2020 [cited 1 March 2022]. Available from: http://www.medel.com/hearing-solutions/cochlear-implants/reliability.
Advanced Bionics Reliability Report 2020. 027-N258-02 Rev D. Advanced Bionics AG and affiliates.; 2021.
Cochlear Limited. D1805413. Cochlear Nucleus Reliability Report, Volume 19 December 2020. 2020, March.